These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22823167)

  • 1. Current strategies for drug discovery through natural products.
    Harvey AL; Clark RL; Mackay SP; Johnston BF
    Expert Opin Drug Discov; 2010 Jun; 5(6):559-68. PubMed ID: 22823167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulators.
    Franco R; Canela EI; Casado V; Ferre S
    Expert Opin Drug Discov; 2010 Apr; 5(4):391-403. PubMed ID: 22823089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of estrogen receptor modulators: a review of virtual screening and SAR efforts.
    Xu X; Yang W; Li Y; Wang Y
    Expert Opin Drug Discov; 2010 Jan; 5(1):21-31. PubMed ID: 22823969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics for bioactivity assessment of natural products.
    Yuliana ND; Khatib A; Choi YH; Verpoorte R
    Phytother Res; 2011 Feb; 25(2):157-69. PubMed ID: 20658470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening strategies for discovery of antibacterial natural products.
    Singh SB; Young K; Miesel L
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):589-613. PubMed ID: 21819327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural products in drug discovery.
    Harvey AL
    Drug Discov Today; 2008 Oct; 13(19-20):894-901. PubMed ID: 18691670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore-based virtual screening: a review of recent applications.
    Kim KH; Kim ND; Seong BL
    Expert Opin Drug Discov; 2010 Mar; 5(3):205-22. PubMed ID: 22823018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When analoging is not enough: scaffold discovery in medicinal chemistry.
    Zhao H; Akritopoulou-Zanze I
    Expert Opin Drug Discov; 2010 Feb; 5(2):123-34. PubMed ID: 22822912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in LC platforms for drug discovery.
    Nicoli R; Martel S; Rudaz S; Wolfender JL; Veuthey JL; Carrupt PA; Guillarme D
    Expert Opin Drug Discov; 2010 May; 5(5):475-89. PubMed ID: 22823131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for discovering drugs from previously unexplored natural products.
    Harvey A
    Drug Discov Today; 2000 Jul; 5(7):294-300. PubMed ID: 10856912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based apoptosis assays in oncology drug discovery.
    Drewe J; Cai SX
    Expert Opin Drug Discov; 2010 Jun; 5(6):583-96. PubMed ID: 22823169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sources for Leads: Natural Products and Libraries.
    van Herwerden EF; Süssmuth RD
    Handb Exp Pharmacol; 2016; 232():91-123. PubMed ID: 26408018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural products as a screening resource.
    Harvey AL
    Curr Opin Chem Biol; 2007 Oct; 11(5):480-4. PubMed ID: 17884696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo design: balancing novelty and confined chemical space.
    Kutchukian PS; Shakhnovich EI
    Expert Opin Drug Discov; 2010 Aug; 5(8):789-812. PubMed ID: 22827800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rediscovering natural products as a source of new drugs.
    Koehn FE; Carter GT
    Discov Med; 2005 Apr; 5(26):159-64. PubMed ID: 20704903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How can high-throughput screening deliver drugs to treat atherosclerosis?
    Yang Y; Wang L; Si S; Hong B
    Expert Opin Drug Discov; 2010 Dec; 5(12):1175-88. PubMed ID: 22822720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of phage display technology for the determination of the targets for small-molecule therapeutics.
    Takakusagi Y; Takakusagi K; Sugawara F; Sakaguchi K
    Expert Opin Drug Discov; 2010 Apr; 5(4):361-89. PubMed ID: 22823088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exemplification of the challenges associated with utilising fluorescence intensity based assays in discovery.
    Gul S; Gribbon P
    Expert Opin Drug Discov; 2010 Jul; 5(7):681-90. PubMed ID: 22823207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-content screening for the discovery of pharmacological compounds: advantages, challenges and potential benefits of recent technological developments.
    Soleilhac E; Nadon R; Lafanechere L
    Expert Opin Drug Discov; 2010 Feb; 5(2):135-44. PubMed ID: 22822913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.